FKRP expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.4864000030812E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.8484000003679E-07 |
Normal-vs-Stage2 |
1.578660E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.481940E-02 |
Stage1-vs-Stage2 |
8.971600E-02 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.346400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.964600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.41000000458891E-08 |
Normal-vs-AfricanAmerican |
1.92020000000515E-06 |
Normal-vs-Asian |
1.049950E-04 |
Caucasian-vs-AfricanAmerican |
5.696100E-02 |
Caucasian-vs-Asian |
4.756800E-01 |
AfricanAmerican-vs-Asian |
1.774030E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.952200E-04 |
Normal-vs-Female |
1.85749999825902E-08 |
Male-vs-Female |
7.127800E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.222600E-04 |
Normal-vs-Extreme_Weight |
1.68479999999027E-05 |
Normal-vs-Obese |
2.077100E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.243800E-01 |
Normal_Weight-vs-Obese |
3.710500E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
9.992300E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.508600E-01 |
Normal-vs-Age(41-60Yrs) |
1.563430E-04 |
Normal-vs-Age(61-80Yrs) |
8.26129999964564E-07 |
Normal-vs-Age(81-100Yrs) |
1.424960E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.712600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.055000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.276600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.002200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.530810E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.714410E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.134800E-01 |
Normal-vs-Grade 3 |
8.783500E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.408200E-01 |
Grade 2-vs-Grade 4 |
2.134800E-01 |
Grade 3-vs-Grade 4 |
8.783500E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.21139999645459E-08 |
Normal-vs-N1 |
2.493900E-02 |
N0-vs-N1 |
4.148200E-01 |
|
|